Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:27:22 2025-06-16 am EDT			5-day change	1st Jan Change
504.20 ^DKK	-2.32%		-2.79%	-19.05%

07:15am	NOVO NORDISK : Gets a Buy rating from JP Morgan	ZD
12:28am	JP Morgan lowers target price for Novo Nordisk to 650 Danish kroner (1,000), reiterates overweight rating - BN	FW

Highlights

Novo Nordisk: amycretin progresses to Phase 3	Jun. 13	CF
Novo Nordisk to Advance Subcutaneous and Oral Amycretin for Weight Management into Phase 3 Clinical Development	Jun. 12	CI
Top Midday Stories: Trump Says China Trade Deal 'Done;' US May Inflation Lower Than Expected	Jun. 11	MT
Novo Nordisk, Deep Apple Sign Deal to Develop Drugs for Cardiometabolic Diseases	Jun. 11	MT
Novo Nordisk Signs Cardiometabolic Diseases Partnership Deal With Deep Apple Therapeutics	Jun. 11	MT
Novo Nordisk Signs Cardiometabolic Diseases Partnership Deal With Deep Apple Therapeutics	Jun. 11	MT
NVIDIA Partners With Novo Nordisk and DCAI to Advance Drug Discovery	Jun. 11	CI
Nvidia Collaborates With Novo Nordisk, DCAI to Use AI for Drug Discovery	Jun. 11	MT
Deep Apple Therapeutics Inc Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapeutics for Cardiometabolic Diseases	Jun. 11	CI
Worldwide Healthcare Trust trails benchmark in "challenging" year	Jun. 11	AN
Health Care Up on Sales Optimism -- Health Care Roundup	Jun. 10	DJ
Novo Nordisk to Present Array of New Portfolio Data Including Studies with Semaglutide and CagriSema, Expanding Evidence in Obesity and Diabetes Care at ADA 2025	Jun. 10	CI
Novo Nordisk: data to be presented at ADA conference	Jun. 10	CF
AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Earnings Forecasts on Rising Competition	Jun. 09	MT
NOVO NORDISK : Baader Europe remains positive, lowers TP	Jun. 09	CF
European Medicines Agency Warns of Visual Side Effect of Novo Nordisk's Ozempic, Wegovy, Rybelsus	Jun. 08	MT
Sector Update: Health Care Stocks Advance in Afternoon Trading	Jun. 06	MT
Novo Nordisk Semaglutide Vision Loss 'Very Rare' Side Effect, European Drug Agency Says	Jun. 06	MT
Hims to acquire UK-based startup Zava as it expands international presence	Jun. 03	RE
Hims to acquire UK-based startup Zava as it expands international presence	Jun. 03	RE
Gerresheimer cuts 2025 outlook on weak demand, shares fall	Jun. 02	RE
FDA Approves Labelling Changes For Trulicity, Saxenda & Xultophy 100/3.6 To Include 'Alopecia' & 'Dysesthesia'	May. 29	RE
Novo Nordisk Receives Positive Opinion From EU Committee on Extension of Saxenda Indication	May. 23	MT
Americans scramble as weight-loss drug discounts fall short, copies face crackdown	May. 23	RE
EMA's CHMP Says Positive Opinion Was Adopted For Blenrep - Website	May. 23	RE